HCNP precursor protein transgenic mice display a depressive-like phenotype in old age

Brain Research

Volumn 1349, Issue , 2010, Pages 153-161

  Matsukawa, Noriyuki ^a   Furuya, Yoshiaki ^b   Ogura, Hiroo ^b   Ojika, Kosei ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

ChAT; Depression; HCNP; Hippocampal cholinergic neurostimulating peptide; Transgenic mice

Indexed keywords

ACETYLCHOLINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; CHOLINE ACETYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; LOCOMOTION; MALE; MAZE TEST; MOOD; MOUSE; NONHUMAN; ONE TAILED TEST; PASSIVE MOVEMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SEPTUM NUCLEUS; SPATIAL MEMORY; WORKING MEMORY;

AGE FACTORS; AGING; ANIMALS; BEHAVIOR, ANIMAL; CHOLINE O-ACETYLTRANSFERASE; DEPRESSION; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; HINDLIMB SUSPENSION; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; NEURAL INHIBITION; NEUROPEPTIDES; PHENOTYPE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; SWIMMING;

MUS; MUS MUSCULUS; RATTUS;

EID: 77955662301     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.06.041     Document Type: Article

References (55)

1. J.T. Andreasen, G.M. Olsen, O. Wiborg, and J.P. Redrobe Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests J. Psychopharmacol. 23 2009 797 804
2. A. Citri, and R.C. Malenka Synaptic plasticity: multiple forms, functions, and mechanisms Neuropsychopharmacology 33 2008 18 41
3. S.R. Cobb, and C.H. Davies Cholinergic modulation of hippocampal cells and circuits J. Physiol. 562 2005 81 88
4. P. Cournoyer, and R.R. Desrosiers Valproic acid enhances protein L-isoaspartyl methyltransferase expression by stimulating extracellular signal-regulated kinase signaling pathway Neuropharmacology 56 2009 839 848
5. R.A. Cunha, S. Ferre, J.M. Vaugeois, and J.F. Chen Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders Curr. Pharm. Des. 14 2008 1512 1524
6. B. Czeh, T. Michaelis, T. Watanabe, J. Frahm, G. de Biurrun, M. van Kampen, A. Bartolomucci, and E. Fuchs Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine Proc. Natl Acad. Sci. USA 98 2001 12796 12801
7. R.S. Duman Novel therapeutic approaches beyond the serotonin receptor Biol. Psychiatry 44 1998 324 335
8. Y. Dwivedi, H.S. Rizavi, R.C. Roberts, R.C. Conley, C.A. Tamminga, and G.N. Pandey Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects J. Neurochem. 77 2001 916 928
9. T. Fujii, K. Nakai, Y. Nakajima, and K. Kawashima Enhancement of hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by repeated lithium treatment in rats Can. J. Physiol. Pharmacol. 78 2000 392 399
10. Y. Furuya, T. Kagaya, H. Ogura, and Y. Nishizawa Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice Eur. J. Pharmacol. 364 1999 133 140
11. C. Geula Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation Neurology 51 1998 S18 29 discussion S65-17
12. E. Gould, P. Tanapat, B.S. McEwen, G. Flugge, and E. Fuchs Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress Proc. Natl Acad. Sci. USA 95 1998 3168 3171
13. S.L. Gourley, F.J. Wu, D.D. Kiraly, J.E. Ploski, A.T. Kedves, R.S. Duman, and J.R. Taylor Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression Biol. Psychiatry 63 2008 353 359
14. C.D. Harvey, R. Yasuda, H. Zhong, and K. Svoboda The spread of Ras activity triggered by activation of a single dendritic spine Science 321 2008 136 140
15. U. Hengst, H. Albrecht, D. Hess, and D. Monard The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors J. Biol. Chem. 276 2001 535 540
16. K. Hisaoka, A. Nishida, T. Koda, M. Miyata, H. Zensho, S. Morinobu, M. Ohta, and S. Yamawaki Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells J. Neurochem. 79 2001 25 34
17. D.S. Janowsky, M.K. el-Yousef, J.M. Davis, B. Hubbard, and H.J. Sekerke Cholinergic reversal of manic symptoms Lancet 1 1972 1236 1237
18. X. Khawaja, J. Xu, J.J. Liang, and J.E. Barrett Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies J. Neurosci. Res. 75 2004 451 460
19. H.G. Kim, and K.L. Kim Decreased hippocampal cholinergic neurostimulating peptide precursor protein associated with stress exposure in rat brain by proteomic analysis J. Neurosci. Res. 85 2007 2898 2908
20. J.H. Kotaleski, and K.T. Blackwell Modelling the molecular mechanisms of synaptic plasticity using systems biology approaches Nat. Rev. Neurosci. 11 2010 239 251
21. V. Lemaire, M. Koehl, M. Le Moal, and D.N. Abrous Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus Proc. Natl Acad. Sci. USA 97 2000 11032 11037
22. B. Li, S. Zhang, M. Li, L. Hertz, and L. Peng Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation Psychopharmacology (Berl) 207 2009 1 12
23. Y. Liu, L. Formisano, I. Savtchouk, Y. Takayasu, G. Szabo, R.S. Zukin, and S.J. Liu A single fear-inducing stimulus induces a transcription-dependent switch in synaptic AMPAR phenotype Nat. Neurosci. 13 2 2009 223 231
24. K. Lorenz, M.J. Lohse, and U. Quitterer Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2 Nature 426 2003 574 579
25. S. Maione, E. Palazzo, M. Pallotta, J. Leyva, L. Berrino, and F. Rossi Effects of imipramine on raphe nuclei and prefrontal cortex extracellular serotonin levels in the rat Psychopharmacology (Berl) 134 1997 401 405
26. M. Maki, N. Matsukawa, H. Yuasa, Y. Otsuka, T. Yamamoto, H. Akatsu, T. Okamoto, R. Ueda, and K. Ojika Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease J. Neuropathol. Exp. Neurol. 61 2002 176 185
27. J.E. Malberg, A.J. Eisch, E.J. Nestler, and R.S. Duman Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J. Neurosci. 20 2000 9104 9110
28. R.I. Martinez-Tellez, E. Hernandez-Torres, C. Gamboa, and G. Flores Prenatal stress alters spine density and dendritic length of nucleus accumbens and hippocampus neurons in rat offspring Synapse 63 2009 794 804
29. N. Matsukawa, K. Ikenaka, K. Nanmoku, H. Yuasa, M. Hattori, M. Kawano, H. Nakazawa, O. Fujimori, R. Ueda, and K. Ojika Brain malformations caused by retroviral vector-mediated gene transfer of hippocampal cholinergic neurostimulating peptide precursor protein into the CNS via embryonic mice ventricles Dev. Neurosci. 25 2003 349 356
30. T. Maurice, M. Hiramatsu, T. Kameyama, T. Hasegawa, and T. Nabeshima Behavioral evidence for a modulating role of sigma ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia Brain Res. 647 1994 57 64
31. C. Mirescu, J.D. Peters, and E. Gould Early life experience alters response of adult neurogenesis to stress Nat. Neurosci. 7 2004 841 846
32. S. Navailles, P.R. Hof, and C. Schmauss Antidepressant drug-induced stimulation of mouse hippocampal neurogenesis is age-dependent and altered by early life stress J. Comp. Neurol. 509 2008 372 381
33. H. Ogura, J. Aruga, and K. Mikoshiba Behavioral abnormalities of Zic1 and Zic2 mutant mice: implications as models for human neurological disorders Behav. Genet. 31 2001 317 324
34. H. Ogura, M. Yasuda, S. Nakamura, H. Yamashita, K. Mikoshiba, and H. Ohmori Neurotoxic damage of granule cells in the dentate gyrus and the cerebellum and cognitive deficit following neonatal administration of phenytoin in mice J. Neuropathol. Exp. Neurol. 61 2002 956 967
35. K. Ojika, S. Kojima, Y. Ueki, N. Fukushima, K. Hayashi, and M. Yamamoto Purification and structural analysis of hippocampal cholinergic neurostimulating peptide Brain Res. 572 1992 164 171
36. K. Ojika, S. Mitake, N. Tohdoh, S.H. Appel, Y. Otsuka, E. Katada, and N. Matsukawa Hippocampal cholinergic neurostimulating peptides (HCNP) Prog. Neurobiol. 60 2000 37 83
37. R.D. Porsolt, A. Bertin, and M. Jalfre "Behavioural despair" in rats and mice: strain differences and the effects of imipramine Eur. J. Pharmacol. 51 1978 291 294
38. B. Porton, R.M. Rodriguiz, L.E. Phillips, J.W.T. Gilbert, J. Feng, P. Greengard, H.T. Kao, and W.C. Wetsel Mice lacking synapsin III show abnormalities in explicit memory and conditioned fear Genes Brain Behav. 2009 [Epub ahead of print]
39. J. Prathiba, K.B. Kumar, and K.S. Karanth Effects of neonatal clomipramine on cholinergic receptor sensitivity and passive avoidance behavior in adult rats J. Neural Transm. Gen. Sect. 100 1995 93 99
40. E.D. Roberson, J.D. English, J.P. Adams, J.C. Selcher, C. Kondratick, and J.D. Sweatt The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus J. Neurosci. 19 1999 4337 4348
41. H. Rollema, M. Hajos, P.A. Seymour, R. Kozak, M.J. Majchrzak, V. Guanowsky, W.E. Horner, D.S. Chapin, W.E. Hoffmann, and D.E. Johnson, et al. Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition Biochem. Pharmacol. 78 2009 813 824
42. L. Rozzini, B. Vicini Chilovi, E. Bertoletti, M. Trabucchi, and A. Padovani Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease Aging Clin. Exp. Res. 19 2007 220 223
43. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 1985 367 370
44. M. Suzuki, C.T. Beuckmann, K. Shikata, H. Ogura, and T. Sawai Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior Brain Res. 1044 2005 116 121
45. J.D. Sweatt The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory J. Neurochem. 76 2001 1 10
46. D. Taliaz, N. Stall, D.E. Dar, and A. Zangen Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis Mol. Psychiatry 15 2010 80 92
47. M. Tanaka, C. Namiki, D.H. Thuy, H. Yoshida, K. Kawasaki, K. Hashikawa, H. Fukuyama, and T. Kita Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease J. Neurol. Sci. 225 2004 135 141
48. R.M. Thomas, G. Hotsenpiller, and D.A. Peterson Acute psychosocial stress reduces cell survival in adult hippocampal neurogenesis without altering proliferation J. Neurosci. 27 2007 2734 2743
49. E. Tiraboschi, D. Tardito, J. Kasahara, S. Moraschi, P. Pruneri, M. Gennarelli, G. Racagni, and M. Popoli Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades Neuropsychopharmacology 29 2004 1831 1840
50. N. Uematsu, N. Matsukawa, T. Kanamori, Y. Arai, T. Sagisaka, T. Toyoda, M. Yoshida, and K. Ojika Overexpression of hippocampal cholinergic neurostimulating peptide in heterozygous transgenic mice increases the amount of ChAT in the medial septal nucleus Brain Res. 1305 2009 150 157
51. K.E. Vogt, and W.G. Regehr Cholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus J. Neurosci. 21 2001 75 83
52. J.W. Wang, D.J. David, J.E. Monckton, F. Battaglia, and R. Hen Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells J. Neurosci. 28 2008 1374 1384
53. X.B. Yan, H.L. Hou, L.M. Wu, J. Liu, and J.N. Zhou Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia Neuropharmacology 53 2007 487 495
54. K. Yeung, T. Seitz, S. Li, P. Janosch, B. McFerran, C. Kaiser, F. Fee, K.D. Katsanakis, D.W. Rose, and H. Mischak, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP Nature 401 1999 173 177
55. L. Zeng, A. Imamoto, and M.R. Rosner Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target Expert Opin. Ther. Targets 12 2008 1275 1287